NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 20,050
-750 (-3.61%)
Apr 10, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 251.51 billion as of April 10, 2026.
Market Cap
251.51B
Enterprise Value
233.27B
Revenue
2.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,050.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 251.51B, an increase of 7.96%. That is a compound annual growth rate of 11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 242.44B | -6.36% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.97T |
| Celltrion | 44.18T |
| ALTEOGEN | 20.04T |
| Samsung Epis Holdings | 12.08T |
| Hyundai Pharmaceutical | 241.63B |
| HLB Pharmaceutical | 230.86B |
| Interojo | 226.45B |
| Chong Kun Dang Holdings | 226.36B |